Back to Search
DAVID SILBERT, MD
MD
Ophthalmology Physician
NPI: 1275593295IndividualAccepts Medicare
Specialties, Licenses & Credentials
Pediatric Ophthalmology and Strabismus Specialist Physician
Ophthalmology — Pediatric Ophthalmology and Strabismus Specialist
Code: 207WX0110X
MD049386L(PA)
Ophthalmology PhysicianPrimary
Ophthalmology
Code: 207W00000X
MD049386L(PA)
CMS Specialties
PrimaryOPHTHALMOLOGY
Education
CLVLND CLINIC LERNER COLLEGE OF MED OF CASE WSTN RSV UNIVERSITY
Class of 1989
Research & Publications (20)
The role of the hepatocyte cytokeratin network in bile formation and resistance to bile acid challenge and cholestasis in mice.
PMID 19585611·Hepatology·2009
7-preclinical
Impact of experimental colitis on hepatobiliary transporter expression and bile duct injury in mice.
PMID 19558576·Liver Int·2009
7-preclinical
Side chain structure determines unique physiologic and therapeutic properties of norursodeoxycholic acid in Mdr2-/- mice.
PMID 19475687·Hepatology·2009
7-preclinical
Balloon catheter dilation and nasolacrimal duct intubation for treatment of nasolacrimal duct obstruction after failed probing.
PMID 19433712·Arch Ophthalmol·2009
4-observational
Accommodative lag by autorefraction and two dynamic retinoscopy methods.
PMID 19214130·Optom Vis Sci·2009
4-observational
Primary treatment of nasolacrimal duct obstruction with balloon catheter dilation in children younger than 4 years of age.
PMID 18929305·J AAPOS·2008
4-observational
Primary treatment of nasolacrimal duct obstruction with nasolacrimal duct intubation in children younger than 4 years of age.
PMID 18595756·J AAPOS·2008
4-observational
Performance of the Plusoptix vision screener for the detection of amblyopia risk factors in children.
PMID 18534881·J AAPOS·2008
8-other
Role of hepatic phospholipids in development of liver injury in Mdr2 (Abcb4) knockout mice.
PMID 18410282·Liver Int·2008
7-preclinical
Primary treatment of nasolacrimal duct obstruction with probing in children younger than 4 years.
PMID 17996306·Ophthalmology·2008
4-observational
Expression of bile acid synthesis and detoxification enzymes and the alternative bile acid efflux pump MRP4 in patients with primary biliary cirrhosis.
PMID 17696930·Liver Int·2007
8-other
Hepatobiliary transporter expression in intercellular adhesion molecule 1 knockout and Fas receptor-deficient mice after common bile duct ligation is independent of the degree of inflammation and oxidative stress.
PMID 17576807·Drug Metab Dispos·2007
7-preclinical
A symptom survey and quality of life questionnaire for nasolacrimal duct obstruction in children.
PMID 16828516·Ophthalmology·2006
4-observational
A randomized trial to evaluate 2 hours of daily patching for strabismic and anisometropic amblyopia in children.
PMID 16751033·Ophthalmology·2006
4-observational
Treatment of anisometropic amblyopia in children with refractive correction.
PMID 16751032·Ophthalmology·2006
4-observational
Coordinated induction of bile acid detoxification and alternative elimination in mice: role of FXR-regulated organic solute transporter-alpha/beta in the adaptive response to bile acids.
PMID 16357057·Am J Physiol Gastrointest Liver Physiol·2006
7-preclinical
Fxr(-/-) mice adapt to biliary obstruction by enhanced phase I detoxification and renal elimination of bile acids.
PMID 16327028·J Lipid Res·2006
7-preclinical
Complementary stimulation of hepatobiliary transport and detoxification systems by rifampicin and ursodeoxycholic acid in humans.
PMID 16083704·Gastroenterology·2005
3-trial
Role of nuclear receptors and hepatocyte-enriched transcription factors for Ntcp repression in biliary obstruction in mouse liver.
PMID 16002565·Am J Physiol Gastrointest Liver Physiol·2005
7-preclinical
A randomized pilot study of near activities versus non-near activities during patching therapy for amblyopia.
PMID 15838439·J AAPOS·2005
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2104 SPRING VALLEY RD
LANCASTER, PA 17601 - Phone
- (717) 541-9700
Quick Facts
- NPI
- 1275593295
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 37
- Publications
- 20
Are you this provider?
Claim Your Profile